Protara Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Protara Therapeutics Inc
CIK #0001359931
EDGAR Form CIK 2011 - 2026
10-K [0001359931]
10-Q [0001359931]
3 [0001359931]
4 [0001359931]
5 [0001359931]
8-K [0001359931]
D [0001359931]
SC 13D [0001359931]
SC 13G [0001359931]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Protara Therapeutics Inc [2026-04-27]
Millennium Management LLC Protara Therapeutics Inc [2026-03-02]
BlackRock Inc Protara Therapeutics Inc [2025-07-17]
Janus Henderson Group PLC Protara Therapeutics Inc [2025-02-14]
Adage Capital Management LP Protara Therapeutics Inc [2025-02-12]
Velan Capital Investment Management LP Protara Therapeutics Inc [2024-12-17]
Opaleye Management Inc Protara Therapeutics Inc [2024-11-18]
Woodline Partners LP Protara Therapeutics Inc [2024-11-14]
RA Capital Management LP Protara Therapeutics Inc [2024-04-25]
Citadel Advisors LLC Protara Therapeutics Inc [2024-04-22]
View All
Form 3/4/5 Subject 2011 - 2026
Shefferman Jesse
Proteon Therapeutics Inc
Levy Richard S
Beshar Luke M
Flannelly Barry P
Garceau Roger
Huang Jane
Sargen Gregory
Smith Cynthia
Solomon Michael Edward
Conkling William
Zummo Jacqueline
Fabbio Patrick
Fry Hannah
Nicacio Leonardo Viana
Opaleye Management Inc
Bandari Jathin
Davis Blaine
Olivo Martin Sebastian
Marshall Randall
Braunstein Scott
Opaleye LP
Casoy Julio
Abingworth LLP
Haines Timothy
Freund John Gordon
Burke Steven Keith
Noyes Timothy P
Hartman Bradley J
Kowalsky Matthew Paul
Eldridge George Arthur
Gottlieb Daniel Philip
Toner E Scott
Deerfield Management Company LP
Flynn James E
Leff Jonathan S
Canute Scott A
Birner Hubert
Bohlin Garen G
Kingsley Stuart A
Hastings Paul J
Deerfield Capital LP
Deerfield International Master Fund LP
Deerfield Partners LP
Deerfield Private Design Fund IV LP
Deerfield Special Situations Fund LP
Deerfield Mgmt III LP
Deerfield Private Design Fund III LP
Deerfield Mgmt IV LP
TVM Life Science Ventures VI GmbH & Co KG
Schuhsler Helmut
TVM Life Science Ventures VI LP
Fischer Stefan
O'Leary Brendan
Phelps Gregory D
Kobyzev Dmitry
Goll Alexandra
Prism Venture Partners V-A LP
Prism Venture Partners V L P
Kaneko Yasunori
Skyline Venture Partners Qualified Purchaser Fund IV L P
Skyline Venture Management IV LLC
Pharmstandard International SA
Joint Stock Co Pharmstandard
Deerfield Special Situations International Master Fund LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Proteon Therapeutics Inc TARA
Common Stock
2026-01-26 Tax withheld 1,457 $6.67 9,718
Proteon Therapeutics Inc TARA
Common Stock
2026-01-26 Tax withheld 8,732 $6.67 58,242
Proteon Therapeutics Inc TARA
Common Stock
2026-01-26 Tax withheld 3,261 $6.67 21,751
Proteon Therapeutics Inc TARA
Common Stock
2026-01-26 Tax withheld 3,724 $6.67 24,839
Proteon Therapeutics Inc TARA
Common Stock
2026-01-20 Tax withheld 3,063 $5.60 17,153
Proteon Therapeutics Inc TARA
Common Stock
2026-01-20 Tax withheld 6,578 $5.60 36,837
Proteon Therapeutics Inc TARA
Common Stock
2026-01-20 Tax withheld 16,322 $5.60 91,403
Proteon Therapeutics Inc TARA
Common Stock
2026-01-20 Tax withheld 2,132 $5.60 11,939
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
2026-01-16 Grant 524,000 $0.00
Proteon Therapeutics Inc TARA
Common Stock
2026-01-16 Grant 87,000 $0.00
Proteon Therapeutics Inc TARA
Common Stock
2026-01-16 Grant 28,000 $0.00
Proteon Therapeutics Inc TARA
Common Stock
2026-01-16 Grant 26,000 $0.00
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
2026-01-16 Grant 158,000 $0.00
Proteon Therapeutics Inc TARA
Common Stock
2026-01-16 Grant 9,500 $0.00
Proteon Therapeutics Inc TARA
Common Stock
2026-01-16 Grant 26,000 $0.00
Proteon Therapeutics Inc TARA
Common Stock
2026-01-16 Grant 30,000 $0.00
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
2026-01-16 Grant 175,000 $0.00
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
2026-01-16 Grant 158,000 $0.00
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
2026-01-16 Grant 180,000 $0.00
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
2026-01-16 Grant 55,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com